ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Probing the Antibiotic Target MurA from S. aureus and B. subtilis
dc.contributor.advisor | Schonbrunn, Ernst | |
dc.contributor.author | Biery, Jennifer J. | |
dc.date.accessioned | 2008-03-01T17:25:53Z | |
dc.date.available | 2008-03-01T17:25:53Z | |
dc.date.issued | 2007-12-18 | |
dc.date.submitted | 2007 | |
dc.identifier.other | http://dissertations.umi.com/ku:2302 | |
dc.identifier.uri | http://hdl.handle.net/1808/1991 | |
dc.description.abstract | MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) catalyzes the first committed step in the biosynthesis of cell wall peptidoglycan. Because this pathway is absent in mammals, MurA is an attractive target for the development of antimicrobial agents. While Escherichia coli and all other gram-negative bacteria possess only one copy of the MurA gene, analyses of the genomes of several gram-positive bacteria reveal the existence of two MurA genes, termed MurA1 and MurA2. The research presented here focuses on the cloning, expression, purification and kinetic characterization of the MurA enzymes from two gram-positive organisms: Staphylococcus aureus and Bacillus subtilis. Sequence analysis indicates that all genes are complete and that the enzymes contain the important catalytic residues previously identified in E. cloacae MurA. Kinetic characterization revealed that the enzymes from both organisms are active and are inhibited by fosfomycin. | |
dc.format.extent | 60 pages | |
dc.language.iso | EN | |
dc.publisher | University of Kansas | |
dc.rights | This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author. | |
dc.subject | Molecular biology | |
dc.subject | Chemistry | |
dc.subject | Biochemistry | |
dc.subject | Mura | |
dc.subject | B. subtilis | |
dc.subject | S. aureus | |
dc.subject | Gram-positive | |
dc.title | Probing the Antibiotic Target MurA from S. aureus and B. subtilis | |
dc.type | Thesis | |
dc.contributor.cmtemember | Scott, Emily E. | |
dc.contributor.cmtemember | Richter, Mark | |
dc.thesis.degreeDiscipline | Medicinal Chemistry | |
dc.thesis.degreeLevel | M.S. | |
kusw.oastatus | na | |
kusw.oapolicy | This item does not meet KU Open Access policy criteria. | |
kusw.bibid | 6599344 | |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Medicinal Chemistry Dissertations and Theses [80]
-
Theses [4088]